CompletedNot Applicable

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

United States16 participantsStarted 2007-12

Plain-language summary

RATIONALE: Polyunsaturated fatty acids are important for normal growth and development. One type, called omega-3 fatty acids (found in fish, fish oil, and some other foods), may affect the growth of abnormal breast cells. PURPOSE: This randomized pilot trial is studying how well omega-3 fatty acids work in treating women with newly diagnosed ductal carcinoma in situ and/or atypical ductal hyperplasia.

Who can participate

Age range21 Years – 120 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Biopsy confirmed diagnosis of any of the following: * Ductal carcinoma in situ (DCIS) and/or atypical ductal hyperplasia (ADH) * DCIS with a component of invasive carcinoma * ADH with a component of invasive carcinoma * DCIS and ADH with a component of invasive carcinoma * Newly diagnosed disease * No pure invasive breast cancer on biopsy without a component of DCIS or ADH * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Female * Menopausal status not specified * Not pregnant * Negative pregnancy test * Speaks English or Spanish * No allergy to fish oil or olive oil * No condition that, in the opinion of the study clinician, would make participation in the study harmful to the patient PRIOR CONCURRENT THERAPY: * No concurrent therapeutic anticoagulation * No concurrent use of fish oil \> 1 g/day

What they're measuring

Effect of omega-3 fatty acids on markers of breast cancer progression

Timeframe: minimum 2 weeks, maximum 8 weeks

Trial details

NCT IDNCT00627276

SponsorOHSU Knight Cancer Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-12